Dow Down 0.17% Nasdaq Down 0.28%

Zogenix, Inc. (ZGNX)

-NasdaqGM
1.15 0.04(3.36%) Sep 30, 4:15PM EDT
Prev Close:1.19
Open:1.18
Bid:1.13 x 2000
Ask:1.55 x 2100
1y Target Est:3.10
Beta:2.28
Next Earnings Date:N/A
Day's Range:1.15 - 1.22
52wk Range:1.14 - 5.19
Volume:1,421,352
Avg Vol (3m):1,894,270
Market Cap:162.20M
P/E (ttm):N/A
EPS (ttm):-0.18
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ZGNX

Comparison

Symbol% ChgMkt Cap
ZGNXDown 3.36%162.20M
AZN90.23B
GSK110.42B
PFE187.50B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.95
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.68
Quarterly EPS Est (Sep-14) :-0.16
Mean Recommendation*:1.2
PEG Ratio (5 yr expected):-0.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders and pain. The company’s commercial product includes Zohydro, a single-entity extended-release hydrocodone for... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback